Results 61 to 70 of about 27,713 (167)

Hospitalist perspectives and practices in treating hospitalized patients with alcohol withdrawal syndrome in the era of phenobarbital re‐emergence

open access: yesJournal of Hospital Medicine, EarlyView.
Abstract Medication treatment for moderate to severe alcohol withdrawal syndrome (AWS) is evolving, particularly with renewed phenobarbital use. However, little research has examined how hospitalists manage AWS. We conducted a multiple‐methods study involving hospitalists from a national US Hospital Medicine research network.
James C. Willey   +9 more
wiley   +1 more source

Clinical study on lorazepam for treating postoperative pain of wound after spinal meningioma surgery

open access: yesChinese Journal of Contemporary Neurology and Neurosurgery, 2017
Objective To estimate the effect of lorazepam in relieving postoperative wound pain and anxiety after spinal meningioma surgery. Methods A total of 106 patients underwent spinal meningioma resection with endotracheal general anesthesia.
Yi-peng WANG, Wen-bin WANG
doaj  

Intramuscular olanzapine versus intramuscular haloperidol plus lorazepam for the treatment of acute schizophrenia with agitation: An open-label, randomized controlled trial

open access: yesJournal of the Formosan Medical Association, 2015
To compare the efficacy and safety profile between intramuscular (IM) olanzapine and IM haloperidol plus IM lorazepam in acute schizophrenic patients with moderate to severe agitation.
Charles Lung-Cheng Huang   +6 more
doaj   +1 more source

Cognitive, Motor and Oculomotor Contributions to the Trail Making Test in Progressive Supranuclear Palsy

open access: yesMovement Disorders Clinical Practice, EarlyView.
Abstract Background Progressive supranuclear palsy (PSP) is a neurodegenerative disorder characterized by motor, oculomotor and cognitive impairments. Yet disentangling cognitive deficits from motor and oculomotor dysfunction remains a diagnostic and methodological challenge.
Indira Garcia‐Cordero   +12 more
wiley   +1 more source

Prevalence of novel psychoactive substances in selected clinical urine specimens submitted for drug monitoring

open access: yesJournal of Forensic Sciences, EarlyView.
Abstract Novel psychoactive substances (NPS) are compounds emerging as alternatives to more established drugs of abuse. They are constantly changing and being modified, which makes their detection difficult. The study objective was to determine the prevalence of NPS in selected clinical specimens. Deidentified urine specimen remnants were analyzed that
Jillian R. Neifeld   +2 more
wiley   +1 more source

Aphasic status epilepticus due to Epstein–Barr virus meningoencephalitis – A clinical vignette

open access: yes
Epileptic Disorders, EarlyView.
Gemma Bassani   +6 more
wiley   +1 more source

Forensic challenges in a case of suspected filicide, matricide, and post‐mortem dismemberment

open access: yesJournal of Forensic Sciences, EarlyView.
Abstract Familicide represents one of the most complex forms of domestic violence in forensic practice. Among intrafamilial homicides, filicide and matricide pose major medico‐legal and criminological challenges, particularly when autopsy findings are nonspecific or severely altered by post‐mortem changes.
Isabella Caristo   +4 more
wiley   +1 more source

Katatoni Tanısı: Lorazepam Testi

open access: yes
Lorazepam testi, katatoni tanısını doğrulamanın yanı sıra tedaviyi de başlatabilir; genellikle daha yüksek dozlar yerine 2 mg önerilmektedir. Lorazepam testinde IV uygulama ideal olmakla birlikte, IV erişim sağlanamadığı durumlarda oral veya IM yol ...
Scott R. Beach
core   +1 more source

Interactive effects of subanesthetic ketamine and subhypnotic lorazepam in humans [PDF]

open access: yes, 1998
 Ketamine is an N -methyl- D -aspartate (NMDA) receptor antagonist with psychotogenic and dissociative effects in healthy humans. These cognitive and perceptual effects in humans are reportedly reduced by benzodiazepine premedication. This study assessed
Bowers Jr. , M. B.   +25 more
core   +2 more sources

Psychedelic‐assisted treatment for substance use disorder: A narrative systematic review

open access: yesAddiction, EarlyView.
Abstract Background and aims This is the first systematic review of the extant literature on all major psychedelic‐assisted treatment for alcohol use disorder (AUD), tobacco use disorder (TUD) and other substance use disorders (SUD). We aimed to summarise the evidence for efficacy of psychedelic‐assisted treatment for AUD, TUD, and SUD; to evaluate its
Theodore Piper   +7 more
wiley   +1 more source

Home - About - Disclaimer - Privacy